Trend and Impact of Concomitant CABG and Multiple-Valve Procedure on In-hospital Outcomes of SAVR Patients

Wu, Jing; Cong, Xiangyu; Lou, Zhiyang; Zhang, Mingyou

doi:10.3389/fcvm.2021.740084

Cited by 14 publications

(8 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, this is different when we consider the second day for CABG and valve replacement procedures. Recently Wu et al 35 , demonstrated that a combination of CABG and valve replacement was associated with worse in-hospital outcomes, including high in-hospital mortality and increased costs.…”

Section: Discussionmentioning

confidence: 99%

Relationship between Perme ICU Mobility Score and length of stay in patients after cardiac surgery

et al. 2022

View full text Add to dashboard Cite

Background:Patients undergoing cardiac surgery can experience functional impairment. Objective:Assess the influence of Perme Score on the intensive care unit (ICU) length of stay in patients after cardiac surgery. As a secondary objective, investigate if preoperative variables can predict the patient's mobility status after surgery. Methods:A prospective observational study was conducted in ICU of a university hospital. The mobility status (Perme Score) was collected from the first postoperative day until ICU discharge. The preoperative assessment of respiratory muscle strength, pulmonary function, and handgrip strength were collected. Results:A total of 44 patients, mean age of 62.3 years, 28 men were included in the study. A high Perme Score on the second postoperative day among patients who underwent Coronary artery bypass grafting and the third postoperative day on three types of intervention (Coronary artery bypass grafting, valve replacement, or both simultaneously) was associated with shorter ICU length of stay). The preoperative pulmonary function was one of the main independent predictors of mobility status on the first three days of ICU stay, in addition to left ventricular ejection fraction and cardiopulmonary bypass time on the first day, age, and left ventricular ejection fraction on the second day and maximum expiratory pressure on the third day. Conclusion:An increase in mobility status (Perme Score), mainly on the third postoperative day, reduced the ICU stay, mainly influenced by preoperative pulmonary function.

show abstract

Section: Discussionmentioning

confidence: 99%

Relationship between Perme ICU Mobility Score and length of stay in patients after cardiac surgery

et al. 2022

View full text Add to dashboard Cite

show abstract

“…In the present study, we queried the NIS database from inception of the ICD-10-CM coding system to the latest available time (from October 2015 through 2019). STEMI hospitalizations were identified using the ICD-10-CM diagnosis codes I21.0x, I21.1x, I21.2x, and I21.3 ( Supplementary Table 1 ), which have been previously validated ( 22 , 23 ). We excluded records of patients who did not undergo PCI; with missing information on the number of treated vessels in procedure codes; with age at admission <18 years; and with missing data on in-hospital mortality ( Supplementary Figure 1 ).…”

Section: Methodsmentioning

confidence: 99%

Multivessel vs. culprit vessel-only percutaneous coronary intervention in ST-segment elevation myocardial infarction with and without cardiogenic shock

Wang

et al. 2022

Front. Cardiovasc. Med.

Self Cite

View full text Add to dashboard Cite

BackgroundEarly revascularization of the culprit vessel is the most effective treatment for reducing the risk of mortality from acute STEMI with and without cardiogenic shock. However, the most recent trends and impact of multivessel percutaneous coronary intervention (PCI) during the index hospitalization on in-hospital outcomes are unknown.MethodsThe National Inpatient Sample was queried from October 2015 to 2019 for hospitalizations with STEMI. The impact of multivessel PCI on in-hospital outcomes of patients with and without cardiogenic shock was evaluated.ResultsOf 624,605 STEMI hospitalizations treated with PCI, 12.5% were complicated by cardiogenic shock. Among hospitalizations without cardiogenic shock, 15.7% were treated by multivessel PCI, which declined from 20.8% in 2015 to 13.9% in 2019 (Ptrend < 0.001). Multivessel and culprit-only PCI had similar rates of In-hospital mortality (2.4 vs. 2.3%, p = 0.027) and major adverse cardiac and cerebrovascular events (MACCE; 7.4 vs. 7.2%, p = 0.072). Among hospitalizations with cardiogenic shock, 22.1% were treated by multivessel PCI, which declined from 29.2% in 2015 to 19.4% in 2019 (Ptrend < 0.001). Multivessel PCI was associated with higher rates of in-hospital mortality (30.9 vs. 28.4%, p < 0.001) and MACCE (39.9 vs. 36.5%, p < 0.001) than culprit-only PCI.ConclusionThe frequency of multivessel PCI for STEMI with and without cardiogenic shock is declining. Multivessel PCI is associated with worse in-hospital outcomes for STEMI with cardiogenic shock but not for STEMI without cardiogenic shock.

show abstract

“…STEMI hospitalizations were identified using the ICD‐10‐CM diagnosis codes I21.0x, I21.1x, I21.2x, and I21.3; NSTEMI hospitalizations were identified using the ICD‐10‐CM diagnosis code I21.3; and ET and PV were identified using the ICD‐10‐CM diagnosis codes D47.3 and D45 15 , 16 , 17 (Table S1 ). All STEMI hospitalizations were included in this study, and only NSTEMI diagnoses coded as the primary diagnosis were included to reduce the heterogeneity of the population with NSTEMI.…”

Section: Methodsmentioning

confidence: 99%

In‐Hospital Outcomes of Acute Myocardial Infarction With Essential Thrombocythemia and Polycythemia Vera: Insights From the National Inpatient Sample

Fan

Zhao

et al. 2022

JAHA

Self Cite

View full text Add to dashboard Cite

Background Acute myocardial infarction (AMI) with essential thrombocythemia (ET) or polycythemia vera is rare, and there are scarce real‐world data on its management and impact on in‐hospital outcomes. Methods and Results Dates of current retrospective cohort study were obtained from the US National Inpatient Sample from October 2015 to 2019 for hospitalizations with AMI. The primary outcome was in‐hospital mortality, and the secondary outcome was major adverse cardiac or cerebrovascular events, stroke, and bleeding; major adverse cardiac or cerebrovascular event was defined by a composite of all‐cause mortality, stroke, and cardiac complications. Of the 2 871 934 weighted AMI hospitalizations, 0.27% were with ET and 0.1% were with polycythemia vera. Before propensity matching, AMI hospitalization with ET was associated with increased risk of in‐hospital mortality (7.1% versus 5.7%; odds ratio [OR], 1.14 [95% CI, 1.04–1.24]), major adverse cardiac or cerebrovascular events (12.6% versus 9%; OR, 1.36 [95% CI, 1.26–1.45]), bleeding (12.7% versus 5.8%; OR, 2.28 [95% CI, 2.13–2.44]), and stroke (3.1% versus 1.8%; OR, 1.66 [95% CI, 1.46–1.89]). Polycythemia vera was associated with an increased risk of in‐hospital mortality (7.8% versus 5.7%; OR, 1.21 [95% CI, 1.04–1.39]) and major adverse cardiac or cerebrovascular events (12.0% versus 9%; OR, 1.18 [95% CI, 1.05–1.33]). After propensity matching, ET was associated with increased risk of bleeding (12.6% versus 6.1%; OR, 2.22 [95% CI, 1.70–2.90]), and AMI with polycythemia vera was not associated with worse in‐hospital outcomes. Conclusions AMI hospitalization with ET is associated with high bleeding risk before and after propensity score matching, particularly for hospitalizations treated with percutaneous coronary intervention. The management of AMI requires a multidisciplinary and patient‐centered approach to ensure safety and improve outcomes.

show abstract

Trend and Impact of Concomitant CABG and Multiple-Valve Procedure on In-hospital Outcomes of SAVR Patients

Cited by 14 publications

References 13 publications

Relationship between Perme ICU Mobility Score and length of stay in patients after cardiac surgery

Relationship between Perme ICU Mobility Score and length of stay in patients after cardiac surgery

Multivessel vs. culprit vessel-only percutaneous coronary intervention in ST-segment elevation myocardial infarction with and without cardiogenic shock

In‐Hospital Outcomes of Acute Myocardial Infarction With Essential Thrombocythemia and Polycythemia Vera: Insights From the National Inpatient Sample

Contact Info

Product

Resources

About